ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mark I. Block
Joel D. Cooper
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Block, M. I.
Right arrow Articles by Cooper, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Block, M. I.
Right arrow Articles by Cooper, J. D.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1997;64:770-776
© 1997 The Society of Thoracic Surgeons


Original Article: General Thoracic

Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography

Mark I. Block, MD, G. Alexander Patterson, MD, R. Sudhir Sundaresan, MD, Marci S. Bailey, RN, Fidelma L. Flanagan, MD, Farrokh Dehdashti, MD, Barry A. Siegel, MD, Joel D. Cooper, MD

Division of Cardiothoracic Surgery, Department of Surgery, and Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

Background. Positron emission tomography with the glucose analogue 2-[18F]fluoro-2-deoxy-D-glucose (FDG) has been used to detect and stage a variety of malignancies. We hypothesized that FDG–positron emission tomography would improve staging of patients with esophageal cancer and thereby facilitate selection of candidates for resection.

Methods. Fifty-eight patients (42 men and 16 women) with biopsy-proven esophageal cancer were evaluated with both FDG–positron emission tomography and computed tomography.

Results. In all but 2 patients, increased FDG uptake was identified at the site of the primary tumor. Six patients were not operative candidates. Seventeen patients were not candidates for resection because of metastatic disease. Positron emission tomography identified the metastatic disease in all 17 (12 of whom underwent confirmatory biopsy), whereas computed tomography was positive for metastases in only 5. The remaining 35 patients underwent surgical exploration, were judged to have resectable disease and had esophagectomy. Pathologic examination of resected specimens identified lymph node metastases in 21 patients. These nodes were detected by positron emission tomography in 11 patients and by computed tomography in 6.

Conclusions. Positron emission tomography improved staging and facilitated selection of patients for operation by detecting distant disease not identified by computed tomography alone.


Related Article

Discussion
Ann. Thorac. Surg. 1997 64: 776-777. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. F. Meyers, R. J. Downey, P. A. Decker, R. J. Keenan, B. A. Siegel, R. J. Cerfolio, R. J. Landreneau, C. E. Reed, D. M. Balfe, F. Dehdashti, et al.
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 738 - 745.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Singh, B. Camazine, Y. Jadhav, R. Gupta, P. Mukhopadhyay, A. Khan, R. Reddy, Q. Zheng, D. D. Smith, R. Khode, et al.
Endoscopic Ultrasound As a First Test for Diagnosis and Staging of Lung Cancer: A Prospective Study
Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 345 - 354.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. M. Blodgett, C. C. Meltzer, and D. W. Townsend
PET/CT: Form and Function
Radiology, February 1, 2007; 242(2): 360 - 385.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Yuan, Y. Yu, K.S. C. Chao, Z. Fu, Y. Yin, T. Liu, S. Chen, X. Yang, G. Yang, H. Guo, et al.
Additional Value of PET/CT over PET in Assessment of Locoregional Lymph Nodes in Thoracic Esophageal Squamous Cell Cancer
J. Nucl. Med., August 1, 2006; 47(8): 1255 - 1259.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Rizk, R. J. Downey, T. Akhurst, M. Gonen, M. S. Bains, S. Larson, and V. Rusch
Preoperative (18)[F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values Predict Survival After Esophageal Adenocarcinoma Resection.
Ann. Thorac. Surg., March 1, 2006; 81(3): 1076 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
M. Tahara, A. Ohtsu, S. Hironaka, N. Boku, S. Ishikura, Y. Miyata, T. Ogino, and S. Yoshida
Clinical Impact of Criteria for Complete Response (CR) of Primary Site to Treatment of Esophageal Cancer
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 316 - 323.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Y. Choi, H.-J. Jang, Y. M. Shim, K. Kim, K. S. Lee, K.-H. Lee, Y. Choi, Y. S. Choe, and B.-T. Kim
18F-FDG PET in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Surgery: Prognostic Implications
J. Nucl. Med., November 1, 2004; 45(11): 1843 - 1850.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
W. Kneist, M. Schreckenberger, P. Bartenstein, C. Menzel, K. Oberholzer, and T. Junginger
Prospective Evaluation of Positron Emission Tomography in the Preoperative Staging of Esophageal Carcinoma
Arch Surg, October 1, 2004; 139(10): 1043 - 1049.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H.L. van Westreenen, M. Westerterp, P.M.M. Bossuyt, J. Pruim, G.W. Sloof, J.J.B. van Lanschot, H. Groen, and J.Th.M. Plukker
Systematic Review of the Staging Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer
J. Clin. Oncol., September 15, 2004; 22(18): 3805 - 3812.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. A.M. Heeren, P. L. Jager, F. Bongaerts, H. van Dullemen, W. Sluiter, and J. Th.M. Plukker
Detection of Distant Metastases in Esophageal Cancer with 18F-FDG PET
J. Nucl. Med., June 1, 2004; 45(6): 980 - 987.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. M. Rohren, T. G. Turkington, and R. E. Coleman
Clinical Applications of PET in Oncology
Radiology, May 1, 2004; 231(2): 305 - 332.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
H. L. van Westreenen, P. A.M. Heeren, P. L. Jager, H. M. van Dullemen, H. Groen, and J. Th.M. Plukker
Pitfalls of Positive Findings in Staging Esophageal Cancer With F-18-Fluorodeoxyglucose Positron Emission Tomography
Ann. Surg. Oncol., November 1, 2003; 10(9): 1100 - 1105.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
S. W. Fosko, W. Hu, T. F. Cook, and V. J. Lowe
Positron Emission Tomography for Basal Cell Carcinoma of the Head and Neck
Arch Dermatol, September 1, 2003; 139(9): 1141 - 1146.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. C. Yoon, K. S. Lee, Y. M. Shim, B.-T. Kim, K. Kim, and T. S. Kim
Metastasis to Regional Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma: CT versus FDG PET for Presurgical Detection— Prospective Study
Radiology, June 1, 2003; 227(3): 764 - 770.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B B Chin and R L Wahl
18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
Gut, June 1, 2003; 52(90004): iv23 - 29.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. J. Downey, T. Akhurst, D. Ilson, R. Ginsberg, M. S. Bains, M. Gonen, H. Koong, M. Gollub, B. D. Minsky, M. Zakowski, et al.
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
J. Clin. Oncol., February 1, 2003; 21(3): 428 - 432.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
S. M. Wren, P. Stijns, and S. Srinivas
Positron Emission Tomography in the Initial Staging of Esophageal Cancer
Arch Surg, September 1, 2002; 137(9): 1001 - 1006.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. W.C. Entwistle III and M. Goldberg
Multimodality therapy for resectable cancer of the thoracic esophagus
Ann. Thorac. Surg., March 1, 2002; 73(3): 1009 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A. Hagen and T. R. DeMeester
Esophageal adenocarcinoma
Ann. Thorac. Surg., October 1, 2001; 72(4): 1430 - 1432.
[Full Text] [PDF]


Home page
ImagingHome page
S F Barrington
Whole body applications of positron emission tomography in oncology
Imaging, September 1, 2001; 13(3): 185 - 196.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Kim, S. J. Park, B.-T. Kim, K. S. Lee, and Y. M. Shim
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography
Ann. Thorac. Surg., January 1, 2001; 71(1): 290 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Flamen, A. Lerut, E. Van Cutsem, J. P. Cambier, A. Maes, W. De Wever, M. Peeters, P. De Leyn, D. Van Raemdonck, and L. Mortelmans
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer
J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1085 - 1092.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Flamen, A. Lerut, E. Van Cutsem, W. De Wever, M. Peeters, S. Stroobants, P. Dupont, G. Bormans, M. Hiele, P. De Leyn, et al.
Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma
J. Clin. Oncol., September 18, 2000; 18(18): 3202 - 3210.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. B. Schneider, C. Clary-Macy, S. Challa, K. C. Sasse, S. H. Merrick, R. Hawkins, G. Caputo, and D. Jablons
Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma
J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 128 - 133.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. J. Skehan, A. L. Brown, M. Thompson, J. E. M. Young, G. Coates, and C. Nahmias
Imaging Features of Primary and Recurrent Esophageal Cancer at FDG PET
RadioGraphics, May 1, 2000; 20(3): 713 - 723.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. D. Luketich, D. M. Friedman, T. L. Weigel, M. A. Meehan, R. J. Keenan, D. W. Townsend, and C. C. Meltzer
Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans
Ann. Thorac. Surg., October 1, 1999; 68(4): 1133 - 1136.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
C. E. Reed
Surgical Management of Esophageal Carcinoma
Oncologist, April 1, 1999; 4(2): 95 - 105.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
C. E. Reed, G. Mishra, A. V. Sahai, B. J. Hoffman, and R. H. Hawes
Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes
Ann. Thorac. Surg., February 1, 1999; 67(2): 319 - 321.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. Weder, R. A. Schmid, H. Bruchhaus, S. Hillinger, G. K. von Schulthess, and H. C. Steinert
Detection of extrathoracic metastases by positron emission tomography in lung cancer
Ann. Thorac. Surg., September 1, 1998; 66(3): 886 - 893.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.